Pinsent Masons advises B&S Group on securing £85 million ABL facilities

20 Dec 2017 | 09:13 am | 1 min. read

International law firm Pinsent Masons has advised B&S Group (B&S), the family-owned integrated pharmaceuticals supply and distribution business, on securing £85 million in asset-based lending (ABL) facilities from a three-bank club led by HSBC Invoice Finance and including Lloyds Bank and BNP Paribas Commercial Finance.

The new ABL facilities will be used to refinance B&S’s existing ABL facilities and support the growth of the business. B&S was advised on the refinancing by KPMG LLP.

Established in 1999, B&S has grown from a two-person business to turnover of £247m in 2017. B&S is headquartered in Perivale, West London, and employs over 500 people. As the UK’s largest parallel importer of pharmaceuticals and the UK’s largest short-line generic pharmaceuticals supplier, B&S supplies more than 4,000 pharmacies across the country.

Prash Patel, B&S’s Chief Financial Officer, said: “B&S is a well controlled disciplined business underpinned by strong family values, and our new ABL facilities provide us with a secure and flexible source of capital to support our operations and strategy going forward. The transaction was made possible by a supportive banking club, and we are grateful for the hard work and close support of our advisers KPMG LLP and Pinsent Masons LLP in helping us to negotiate a deal on competitive terms.”

Edward Sunderland, Structured Finance Partner at Pinsent Masons LLP, said: “This was our first transaction with B&S, who appointed us following a competitive process due to our firm wide expertise in both ABL financing and complex Pharmaceutical sector knowledge. We look forward to supporting them in their future growth plans.”

Marc Finer, Director, KPMG LLP, who leads KPMG’s debt advice on ABL transactions, added: “The terms of the deal, which saw several operating improvements to B&S’s previous ABL facilities, reflect strong lending appetite among ABL lenders for new deals. The smooth execution of a three-bank deal, which included B&S bringing a new lender into its business alongside two incumbent financiers, demonstrates the maturity of the ABL market.”

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises Australian Gas Infrastructure Group on its landmark A$4 billion debt programme

Multinational law firm Pinsent Masons advised Australian Gas Infrastructure Group (AGIG), one of the largest gas infrastructure businesses in Australia, on its new funding vehicle and secured AUS$4 billion debt programme.

Pinsent Masons advises on $85m Taif independent sewage treatment plant in Saudi Arabia

Multinational law firm Pinsent Masons has advised the sponsors on the Taif independent wastewater treatment plant project in Saudi Arabia, with assistance from our associated Saudi Arabia law firm AlSabhan & AlAjaji.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts